The Morphologic and Immunohistochemical Spectrum of Papillary Renal Cell Carcinoma Study Including 132 Cases With Pure Type 1 and Type 2 Morphology As Well As Tumors With Overlapping Features

被引:45
作者
Chevarie-Davis, Myriam [1 ]
Riazalhosseini, Yasser [2 ,4 ,5 ]
Arseneault, Madeleine [2 ,4 ,5 ]
Aprikian, Armen [3 ]
Kassouf, Wassim [3 ]
Tanguay, Simon [3 ]
Latour, Mathieu [6 ]
Brimo, Fadi [1 ]
机构
[1] McGill Univ, Dept Pathol, Montreal, PQ H3A 2T5, Canada
[2] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2T5, Canada
[3] McGill Univ, Dept Urol, Montreal, PQ H3A 2T5, Canada
[4] McGill Univ, Montreal, PQ H3A 2T5, Canada
[5] Genome Quebec Innovat Ctr, Quebec City, PQ, Canada
[6] Univ Montreal, Montreal, PQ H3C 3J7, Canada
关键词
papillary; renal cell carcinoma; nucleoli; immunohistochemistry; stage; SNP array; CLINICOPATHOLOGICAL CHARACTERISTICS; DIFFERENTIAL EXPRESSION; HISTOLOGICAL SUBTYPES; PROGNOSTIC IMPACT; TYPE-1; CLASSIFICATION; SURVIVAL; TUMORS; GRADE;
D O I
10.1097/PAS.0000000000000247
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Papillary renal cell carcinomas (pRCC) are classically divided into type 1 and 2 tumors. However, many cases do not fulfill all the criteria for either type. We describe the clinical, morphologic, and immunohistochemical (IHC) features of 132 pRCCs to better characterize the frequency and nature of tumors with overlapping features. Cases were reviewed and classified; IHC evaluation of CK7, EMA, TopoII alpha, napsin A, and AMACR was performed on 95 cases. The frequencies of type 1, type 2, and "overlapping" pRCC were 25%, 28%, and 47%, respectively. The 2 categories of "overlapping" tumors were: (1) cases with bland cuboidal cells but no basophilic cytoplasm (type A); and (2) cases with predominantly type 1 histology admixed with areas showing prominent nucleoli (type B). The pathologic stage of "overlapping" cases showed concordance with type 1 tumors. Using the 2 discriminatory markers (CK7, EMA), "type A" cases were similar to type 1. Although the high-nuclear grade areas of "type B" tumors showed some staining differences from their low-nuclear grade counterpart, their IHC profile was closer to type 1. Single nucleotide polymorphism array results, although preliminary and restricted to only 9 cases (3 with overlapping features), also seemed to confirm those findings. In conclusion, we demonstrate that variations in cytoplasmic quality and/or presence of high-grade nuclei in tumors otherwise displaying features of type 1 pRCCs are similar in stage and IHC profile those with classic type 1 histology, suggesting that their spectrum might be wider than originally described.
引用
收藏
页码:887 / 894
页数:8
相关论文
共 27 条
[1]   Papillary (chromophil) renal cell carcinoma: Histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases [J].
Amin, MB ;
Corless, CL ;
Renshaw, AA ;
Tickoo, SK ;
Kubus, J ;
Schultz, DS .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (06) :621-635
[2]   Prognostic impact of histologic Subtyping of adult renal epithelial neoplasms - An experience of 405 cases [J].
Amin, MB ;
Amin, MB ;
Tamboli, P ;
Javidan, J ;
Stricker, H ;
Venturina, MD ;
Deshpande, A ;
Menon, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (03) :281-291
[3]   Cytogenetic features, clinical significance and prognostic impact of type 1 and type 2 papillary renal cell carcinoma [J].
Antonelli, Alessandro ;
Tardanico, Regina ;
Balzarini, Piera ;
Arrighi, Nicola ;
Perucchini, Laura ;
Zanotelli, Tiziano ;
Cozzoli, Alberto ;
Zani, Danilo ;
Cunico, Sergio Cosciani ;
Simeone, Claudio .
CANCER GENETICS AND CYTOGENETICS, 2010, 199 (02) :128-133
[4]  
Delahunt B, 1997, MODERN PATHOL, V10, P537
[5]   Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 cases [J].
Delahunt, B ;
Eble, JN ;
McCredie, MRE ;
Bethwaite, PB ;
Stewart, JH ;
Bilous, AM .
HUMAN PATHOLOGY, 2001, 32 (06) :590-595
[6]   Expression and Amplification of Topoisomerase-2α in Type 1 and Type 2 Papillary Renal Cell Carcinomas and Its Correlation with HER2/neu Amplification [J].
Duzcan, Fusun ;
Duzcan, Suleyman Ender ;
Sen, Sait ;
Yorukoglu, Kutsal ;
Caner, Vildan ;
Sen Turk, Nilay ;
Cetin, Gokhan Ozan ;
Kelten, Canan ;
Tuna, Burcin ;
Sarsik, Banu ;
Tepeli, Emre .
PATHOLOGY & ONCOLOGY RESEARCH, 2011, 17 (03) :697-703
[7]  
Eble JN, 2004, PATHOLGY GENETICS TU
[8]   Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma [J].
Furge, Kyle A. ;
Chen, Jindong ;
Koeman, Julie ;
Swiatek, Pamela ;
Dykema, Karl ;
Lucin, Kseniji ;
Kahnoski, Richard ;
Yang, Ximing J. ;
Teh, Bin Tean .
CANCER RESEARCH, 2007, 67 (07) :3171-3176
[9]  
Gunawan B, 2003, CANCER RES, V63, P6200
[10]  
Hes Ondrej, 2006, Ann Diagn Pathol, V10, P133, DOI 10.1016/j.anndiagpath.2005.12.002